Masao Hashimoto
Overview
Explore the profile of Masao Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Codarri Deak L, Hashimoto M, Umana P, Klein C
Oncoimmunology
. 2023 Apr;
12(1):2197360.
PMID: 37025392
The immunocytokine PD1-IL2v was designed to overcome liabilities and improve efficacy of IL-2 therapies. PD1-IL2v preferentially targets PD-1 T-cells and acts on antigen-specific stem-like PD-1 TCF-1 CD8 T-cells expanding and...
12.
Katsuno T, Suzuki M, Morishita M, Kawajiri K, Saito S, Horikawa Y, et al.
Glob Health Med
. 2023 Mar;
5(1):47-53.
PMID: 36865899
High-flow nasal cannula (HFNC) can be effective in treating type 1 respiratory failure by reducing the severity of coronavirus disease 2019 (COVID-19). The purpose of this study was to assess...
13.
Ando S, Perkins C, Sajiki Y, Chastain C, Valanparambil R, Wieland A, et al.
J Clin Invest
. 2022 Nov;
133(2).
PMID: 36378537
T cell exhaustion is a state of T cell dysfunction associated with expression of programmed death 1 (PD-1). Exhausted CD8+ T cells are maintained by self-renewing stem-like T cells that...
14.
Hashimoto M, Araki K, Cardenas M, Li P, Jadhav R, Kissick H, et al.
Nature
. 2022 Sep;
610(7930):173-181.
PMID: 36171288
Combination therapy with PD-1 blockade and IL-2 is highly effective during chronic lymphocytic choriomeningitis virus infection. Here we examine the underlying basis for this synergy. We show that PD-1 + ...
15.
Codarri Deak L, Nicolini V, Hashimoto M, Karagianni M, Schwalie P, Lauener L, et al.
Nature
. 2022 Sep;
610(7930):161-172.
PMID: 36171284
Expansion and differentiation of antigen-experienced PD-1TCF-1 stem-like CD8 T cells into effector cells is critical for the success of immunotherapies based on PD-1 blockade. Hashimoto et al. have shown that,...
16.
Suzuki M, Watanabe H, Hashimoto M, Ishii S, Naka G, Iikura M, et al.
Radiol Case Rep
. 2022 Sep;
17(11):4232-4238.
PMID: 36120524
Pulmonary hamartomas are common benign lung tumors; however, endobronchial hamartomas are relatively rare. We report a case of asymptomatic endobronchial hamartoma in a 51-year-old man. Chest computed tomography revealed a...
17.
Ishida A, Ushio A, Hashimoto M, Ishii S, Naka G, Iikura M, et al.
Thorac Cancer
. 2022 May;
13(14):2075-2077.
PMID: 35595502
Docetaxel is a cytotoxic taxane frequently used to treat patients with various cancers, including non-small cell lung cancer (NSCLC). Docetaxel is known to cause acute myalgias, arthralgias, and neuropathy, but...
18.
So C, Izumi S, Ishida A, Hirakawa R, Kusaba Y, Hashimoto M, et al.
Respirol Case Rep
. 2022 Mar;
10(4):e0938.
PMID: 35355663
The Pfizer-BioNTech mRNA vaccine (BNT162b2) is an effective and well-tolerated coronavirus disease 2019 (COVID-19) vaccine. However, rare adverse events have been reported. We report two cases of COVID-19 mRNA vaccine-related...
19.
Morishita M, Suzuki M, Matsunaga A, Ishizhima K, Yamamoto T, Kuroda Y, et al.
J Infect Chemother
. 2022 Feb;
28(7):971-974.
PMID: 35184976
Corticosteroids are widely used to treat severe COVID-19, but in immunocompromised individuals, who are susceptible to persistent infection, long term corticosteroid use may delay viral clearance. We present a case...
20.
Yamaguchi Y, Hashimoto M, Saito S, Morita T, Tsukada A, Kusaba Y, et al.
Intern Med
. 2022 Jan;
61(6):913-916.
PMID: 34980790
A 33-year-old woman with a fever, cough, and pharyngitis was admitted after left-sided pleural effusion was detected. The fever and upper respiratory symptoms were confirmed, and she was diagnosed with...